The brain's invisible proofreader: what A-to-I RNA editing really does
Every day, your cells silently rewrite millions of RNA letters. Here is how ADAR enzymes do it, why neurons and glia depend on it — and why scientists want to borrow the trick.
When scientists say a gene “makes a protein,” they usually skip a fascinating middle chapter. The DNA is first copied into RNA, and only then does the RNA get read to build the protein. That middle chapter — the RNA — is not a faithful photocopy. Your cells actively edit it.
The most common edit in the human body is tiny but mighty: a single letter, A, gets chemically converted into something the cell reads as G. This is A-to-I RNA editing, and it is carried out by a family of enzymes called ADAR (adenosine deaminases acting on RNA).
Millions of edits, every day
In a typical week, your cells perform millions of these edits — the overwhelming majority inside the brain. Some edits tweak the fine-tuning of proteins in neurons, changing things like how quickly a nerve signal decays. Others don’t change proteins at all; instead they mark RNA molecules for stabilization or destruction. When this editing system underperforms, the consequences are serious: mice lacking ADAR enzymes develop dramatic brain inflammation and die within weeks, and rare human mutations in the same genes cause severe neurodevelopmental disease.
Why scientists want to borrow it
Here is the tempting part: ADAR enzymes are already inside every one of our cells. So instead of cutting DNA with CRISPR nucleases — a permanent change with real safety questions — researchers have designed guide RNAs that recruit the cell’s own ADAR to a disease-causing letter, flipping it back to the healthy version. The edit stays RNA-only and gradually fades unless renewed, which makes it inherently reversible.
That is the strategy our lab pursues: designing RNA sensors that use endogenous ADAR to retune disease-relevant transcripts. In a recent preprint, we showed the approach can precisely engage inflammatory astrocyte subpopulations in human stem-cell models of the brain.
Why the brain cares so much
RNA editing is strikingly enriched in neurons and glia, and large-scale studies have found editing patterns altered in Alzheimer’s disease, ALS, and epilepsy. A working hypothesis in the field is that some diseases are partly editing diseases — not caused by a broken gene, but by an RNA message that should have been corrected and wasn’t.
Restoring the correction — with the cell’s own enzyme — is exactly the kind of gentle intervention worth chasing.
Questions or thoughts? Get in touch — I read every message.